曾英彤,杨敏,伍俊妍,郑志华,王勇
ZENG Yingtong,YANG Min,WU Junyan,ZHENG Zhihua,WANG Yong

• 1:广东省医学科学院广东省人民医院
• 2:中山大学孙逸仙纪念医院
• 3:广东省药学会

摘要(Abstract)：

"处方精简(Deprescribing)"于2003年由Woodward MC首先提出,是指对可能导致患者损害或患者不再获益的用药,减少该药剂量或停用该药的计划和管理过程;其目标是减少用药负担和损害,同时维持或提高生活质量。多重用药对老年人具有较大的风险,在有效管理和监控下,处方精简是可行和安全的。处方精简流程和步骤包括:评估患者的用药是否有利于目前的适应证;权衡继续用药的获益与害处;制订处方精简的计划并进行沟通;对处方进行精简并进行监控。
The word "Deprescribing"was created by Woodward MC in 2003,which is defined as the planned and supervised process of dose reduction or stopping of medication that may be causing harm or no longer be of benefit. The goal of deprescribing is to reduce medication burden and harm,while maintaining or improving quality of life. Polypharmacy in the elderly carries numerous risks.Deprescribing is feasible and safe when supervised and monitored.All deprescribing algorithms and"steps"include: evaluating need for ongoing indication of each medication,weighing benefit and harm of continuing,developing and communicating a plan for deprescribing,and carrying out deprescribing actions and monitoring.

关键词(KeyWords)： 处方精简;多重用药;慢病管理
deprescribing;polypharmacy;chronic disease management

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 曾英彤,杨敏,伍俊妍,郑志华,王勇
ZENG Yingtong,YANG Min,WU Junyan,ZHENG Zhihua,WANG Yong

参考文献(References)：

• [1]Woodward M C.Deprescribing:Achieving Better Health Outcomes for Older People Through Reducing Medications[J].J Pharm Pract Res,2003,33(4):323-328.
• [2]Reason B,Terner M,Moses Mc Keag A,et al.The impact of polypharmacy on the health of Canadian seniors[J].Family Practice,2012,29(4):427-432.
• [3]Kwan D,Farrell B.Polypharmacy:optimizing medication use in elderly patients[J].CGS Journal of CME,2014,4:21-27.
• [4]Page A T,Potter K,Clifford R,et al.Deprescribing in older people[J].Maturitas,2016,91:115-134.
• [5]C.I.H.I.Seniors and Drugs:an in-depth look.CIHI,2014 serial on the Internet[EB].https://www.cihi.ca/en/seniors_public_sum_en.pdf.
• [6].Morgan S G,Hunt J,Rioux J,et al.Frequency and cost of potentially inappropriate prescribing for older adults:a cross-sectional study[J].CMAJ Open,2016,4(2):346-351.
• [7]Farrell B,Pottie K,Rojas-Fernandez C H,et al.Methodology for Developing Deprescribing Guidelines:Using Evidence and GRADE to Guide Recommendations for Deprescribing[J].PLo S One,2016,11(8):e0161248.
• [8]Farrell B,Tannenbaum C.What is Deprescribing?[EB].http://deprescribing.org/what-is-deprescribing/.
• [9]Page A T,Clifford R M,Potter K,et al.The feasibility and effect of deprescribing in older adults on mortality and health:a systematic review and meta-analysis[J].British Journal of Clinical Pharmacology,2016,82(2):583-623.
• [10]Garfinkel D,Mangin D.Feasibility study of a systematic approach for discontinuation of multiple medications in older adults:addressing polypharmacy[J].Archives of Internal Medicine,2010,8(4):1648-1654.
• [11]Iyer S,Naganathan V,Mc Lachlan A J,et al.Medication withdrawal trials in people aged 65 years and older:a systematic review[J].Drugs Aging,2008,25(12):1021-1231.
• [12]Reeve E,Shakib S,Hendrix I,et al.Review of deprescribing processes and development of an evidence-based,patient-centred deprescribing process[J].British Journal of Clinical Pharmacology,2014,78(4):738-747.
• [13]Hardy J E,Hilmer S N.Deprescribing in the last year of life[J].J Pharm Pract Res,2011,41(2):146-151.
• [14]Lemay G,Dalziel B.Better prescribing in the elderly[J].CGS Journal of CME,2012,2:20-26.
• [15]Scott I A,Hilmer S N,Reeve E,et al.Reducing inappropriate polypharmacy:the process of deprescribing[J].JAMA Intern Med,2015,175(5):827-834.
• [16]Bpac.A practical guide to stopping medicines in older people[J/OL].Best Practice Journal,2010(27):http://www.bpac.org.nz/BPJ/2010/April/stopguide.aspx.
• [17]Bain K T,Holmes H M,Beers M H,et al.Discontinuing medications:a novel approach for revising the prescribing stage of the medication-use process[J].J Am Geriatr Soc,2008,56(10):1946-1952.
• [18]Graves T,Hanlon J T,Schmader K E,et al.Adverse events after discontinuing medications in elderly outpatients[J].Archives of Internal Medicine,1997,157(19):2205-2210.
• [19]Reeve E,Thompson W,Farrell B.Deprescribing:A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action[J].European Journal of Internal Medicine,2017,38:3-11.
• [20]Reeve E,Wiese M D,Hendrix I,et al.People's attitudes,beliefs,and experiences regarding polypharmacy and willingness to Deprescribe[J].J Am Geriatr Soc,2013,61(9):1508-1514.
• [21]Qi K,Reeve E,Hilmer S N,et al.Older peoples'attitudes regarding polypharmacy,statin use and willingness to have statins deprescribed in Australia[J].Int J Clin Pharm,2015,37(5):949-957.
• [22]Galazzi A,Lusignani M,Chiarelli M T,et al.Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy[J].Int J Clin Pharm,2016,38(2):454-461.
• [23]Sirois C,Ouellet N,Reeve E.Community-dwelling older people's attitudes towards deprescribing in Canada[J].Res Social Adm Pharm,2017,13(4):864-870.
• [24]Farrell B,Tannenbaum C.Deprescribing Guidelines and Algorithms[EB].http://deprescribing.org/resources/deprescribing-guidelines-algorithms/.
• [25]Jansen J,Naganathan V,Carter S M,et al.Too much medicine in older people?Deprescribing through shared decision making[J].BMJ,2016,353:i2893.